Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD

Open access
Marco, Giovana S. Di, Reuter, Stefan, Hillebrand, Uta, Amler, Susanne, König, Maximilian, Larger, Etienne, Oberleithner, Hans, Brand, Eva, Pavenstädt, Hermann, Brand, Marcus · 2009 · Journal of the American Society of Nephrology

Abstract

Endothelial dysfunction contributes to the increased cardiovascular risk that accompanies CKD. We hypothesized that the soluble VEGF receptor 1 (sFlt-1), a VEGF antagonist, plays a role in endothelial dysfunction and decreased angiogenesis in CKD. We enrolled 130 patients with CKD stages 3 to 5 and 56 age- and gender-matched control patients. Plasma sFlt-1 levels were higher in patients with CKD and, after multivariate regression analyses, exclusively associated with renal function and levels of vWF, a marker of endothelial dysfunction. Compared with serum from control patients, both recombinant sFlt-1 and serum from patients with CKD had antiangiogenic activity in the chick chorioallantoic membrane (CAM) assay, induced endothelial cell apoptosis in vitro, and decreased nitric oxide generation in two different endothelial cell lines. Pretreating the sera with an antibody against sFlt-1 abrogated all of these effects. Furthermore, we observed increased sFlt1 levels in 5/6-nephrectomized rats compared with sham-operated animals. Finally, using real-time PCR and ELISA, we identified monocytes as a possible source of increased sFlt-1 in patients with CKD. Our findings show that excess sFlt-1 associates with endothelial dysfunction in CKD and suggest that increased sFlt-1 may predict cardiovascular risk in CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2009010061

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 194

Metadata

Authors
Marco, G. S. D., Reuter, S., Hillebrand, U., Amler, S., König, M., Larger, E., Oberleithner, H., Brand, E., Pavenstädt, H., & Brand, M.
Venue
Journal of the American Society of Nephrology
Published
2009-10
Volume
20
Issue
10
Pages
2235-2245
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2097960717
Cited by
194
References
3
FWCI
5.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD. https://app.cochat.ai/papers/10.1681/asn.2009010061
The paper
Marco, G. S. D., Reuter, S., Hillebrand, U., Amler, S., König, M., Larger, E., Oberleithner, H., Brand, E., Pavenstädt, H., & Brand, M. (2009). The Soluble VEGF Receptor sFlt1 Contributes to Endothelial Dysfunction in CKD. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2009010061

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.